Dr. Frederick Greene, our Chief Medical Officer has leveraged his extensive surgical experience and his ongoing editorial experiences with the AJCC and CoC to drive several initiatives for CRStar - including the industry's first podcast focused on Cancer Registry.
Cancer immunotherapies use the body’s own immune system to fight off cancer. Despite some remarkable success stories, many patients only see a temporary improvement before the immunotherapy stops being effective and the tumors regrow. It is unclear why this occurs, but it may have to do with how the immune system attacks cancer cells. Immunotherapies […]
Single cell sequencing is a powerful technology that uses a machine to separate thousands to millions of cells and sequence the genetic material of each cell independently. This increases the resolution of the cellular differences within a diverse population of cells, such as in a tumor. As one example, in a recent study using single […]
During the coronavirus pandemic, national guidelines recommended that elective surgery be deferred when hospital resources are limited. The impact of this delay on outcomes of patients with cancer is unknown. A recent study evaluated the effect of delay of surgery for esophageal cancer during the period 2010-2017. Using the data from the National Cancer Database, […]
The concepts of Diversity, Equity, and Inclusion (DEI) have appropriately become important goals for healthcare enterprises, corporate entities, professional organizations and academic institutions. It is important that these concepts are also being emphasized in professional schools, especially medical schools, where the future generations of physicians are being trained. Twenty-four medical schools throughout the nation will […]
Although node-positive solid tumor malignancies frequently mandate adjuvant chemotherapy usage, the debate regarding Stage II (node negative) colon cancer continues to be ongoing relating to this issue. Medical oncologists have a variety of differing views as to whether additional chemotherapy should be offered after colectomy. While nodal status is an important indicator that is captured […]
